/A%20close-up%20of%20an%20AMD%20office%20by%20gehapromo%20via%20Adobe%20Stock.jpeg)
Amid elevated bond yields, high oil prices, interest rates, and talks of superintelligence, maverick investor Cathie Wood has uncharacteristically stayed away from the spotlight. Known for making outsized bets on companies like Tesla (TSLA) and Palantir (PLTR) when it was not fashionable, Wood has amassed an enviable following in the world of investing.
However, Wood's latest moves in the market are certainly noteworthy, and the investing community has taken note of them again. While the funds overseen by Wood may have bought shares of Nvidia (NVDA) and biotech company Intellia Therapeutics (NTLA) in substantial numbers, it is her largest sale that has grabbed more attention.
